Related Experiment Videos
[Left ventricular function in patients under peritoneal dialysis treatment].
Giornale Italiano Di Cardiologia
|August 1, 1984
Summary
Peritoneal dialysis significantly improves cardiac function in patients with end-stage chronic renal failure. This treatment helps both dilated cardiomyopathy and asymmetric septal hypertrophy, enhancing overall heart health.
Area of Science:
- Cardiology
- Nephrology
- Medical Imaging
Context:
- End-stage chronic renal failure (CRF) often leads to significant cardiac complications.
- Left ventricular function can be compromised in CRF patients, presenting as dilated cardiomyopathy or asymmetric septal hypertrophy.
- Echocardiography is crucial for assessing cardiac morphology and function in CRF.
Purpose:
- To evaluate the impact of peritoneal dialysis (PD) on left ventricular function in patients with end-stage CRF.
- To assess changes in echocardiographic parameters before and after PD treatment.
- To identify specific cardiac patterns associated with CRF and their response to PD.
Summary:
- M-mode echocardiograms and systolic time intervals were analyzed in 24 end-stage CRF patients before and after PD.
- Patients exhibited patterns of dilated cardiomyopathy (Group A), asymmetric septal hypertrophy (Group B), or non-specific myocardial derangement (Group C).
- PD treatment led to improved contractile state in Group A, reduced septal hypertrophy in Group B, and enhanced cardiac performance in Group C.
Impact:
- End-stage CRF can manifest with distinct echocardiographic findings of cardiomyopathy.
- Peritoneal dialysis demonstrates significant efficacy in improving both morphological and functional cardiac derangements in CRF patients.
- This study highlights PD as a beneficial therapeutic option for managing cardiac complications associated with chronic kidney disease.